Herpes zoster ophthalmicus

Clinical and Experimental Optometry

Volumn 83, Issue 2, 2000, Pages 59-64

  Cockburn, David M ^a   Douglas, Ian S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Complications; Herpes zoster ophthalmicus; Management guidelines

Indexed keywords

EID: 85015175739     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2000.tb04893.x     Document Type: Article

References (27)

1. Raggozzino MW, Melton LJ, Kurland LT et al. Population based stvidies of herpes zoster and its sequelae. Medicine 1982; 61: 310–316.
2. Balfour HH. Varicella zoster virus infections in immunocompromised hosts: a review of the natural history and management. Am J Med 1988; 85: 68–73.
3. Liesegang TJ. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology 1991; 98: 1216–1219.
4. Friedman-Klien AE, Lafleur FL, Glendler E. Herpes Zoster: A possible early sign for the development of acquired immunodeficiency syndrome in high-risk individuals. J Am Acad Dermatol 1986: 14: 1023–1028.
5. Mescon H, Bachta M. Dermatology in general practice in Medicine In: Wilkins RW, Levinsky NG eds. Essentials of Clinical Practice. Boston: Little Brown, 1978: 66.
6. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 1965; 58: 9–20.
7. Marsh RJ, Cooper M. Ophthalmic herpes zoster. Eye 1993; 7: 350–370.
8. Beeson PB, McDermott W. Textbook of Medicine, 14th ed. Philadelphia: WB Saunders, 1975: 66.
9. Awan Kf. Total ocular motor palsy as a presentation of herpes zoster ophthalmicus. Pak J Ophthalmol 1989; 66: 84.
10. Kanski JJ. Clinical Ophthalmology. London: Butterworths, 1984: 510.
11. Higginbotham E, Lee DA. Management of Difficult Glaucoma. Boston: Blackwell, 1994: 131.
12. Snider GL. Diseases of the pleura. In: Medicine: Essentials of Clinical Practice, 2nd ed. Boston: Little Brown 1978: 208.
13. Nagington J, Rubenstein D. Viruses. In: Weatherall DJ, Ledingham JGG, Warrell DA eds. Oxford Text Book of Medicine. Oxford: Oxford University Press, 1983; 5: 45.
14. Murtagh J. General Practice Sydney: McGraw-Hill, 1996: 885.
15. Merk Manual of Diagnosis and Therapy, 17th ed. Whitehouse Station Merk & Co 1999).
16. Cobo LM, Foulks GN, Liesegang T, Lass J et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1986; 93: 763–770.
17. Hoang-Xuan T, Buchi ER, Herbort CP, Denis J et al. Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology 1992; 99:1062–1071.
18. Herbort CP. Acylovir in herpes zoster ophthalmicus. Br J Ophthalmol 1992; 76: 639.
19. Marsh JR. Reply: Acyclovir in herpes zoster ophthalmicus. Br J Ophthalmol 1992; 76: 639.
20. Liesegang TJ. Herpes Zoster. In: Mannis MJ, Macsai MS, Huntly AC eds. Eye and Skin Disease. Philadephia: Lippincroft-Raven, 1996 466.
21. Lloyd AR. Varicella and herpes zoster. In: Mims Disease Index. Crows Nest: IMS Publishing, 1992: 585.
22. McGill J. Topical acyclovir in herpes zoster ocular involvement. Br J Ophthalmol 1981; 65: 542–545.
23. Marsh RJ, Cooper M. Acyclovir and steroids. In: Herpes Zoster Keratouveitis. Br J Ophthalmol 1984; 68: 904.
24. Marsh RJ, Cooper M. Double masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation. Br J Ophthalmol 1991; 75; 542–546.
25. Warwar RE, Bullock JD, Ballal D. Cystoid macular oedema and anterior uveitis associated with latanoprost use. Ophthalmology 1998; 105: 263–268.
26. Fetchner RD, Khouri AS, Zimmerman TJ, Bullock J et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol 1998; 126: 37–41.
27. Weibel RE, Neff BJ, Kuter BJ et al. Live attenuated varicella virus vaccine efficiency trial in children. N Eng J Med. 1984; 310: 1409–1415.